Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chunliu Meng"'
Autor:
Tao Jiang, Jiao Tian, Peijie Lei, Chunliu Meng, Jialei Fu, Lianjing Cao, Jingjing Cheng, Fei Zhou, Hongjun Zhang, Hao Song, Haijun Lu, Xiaojuan Wei
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Purpose This study aims to investigate the effects of chest wall bolus in intensity-modulated radiotherapy (IMRT) technology on clinical outcomes for post-mastectomy breast cancer patients. Materials and methods This retrospective study incl
Externí odkaz:
https://doaj.org/article/f3be92e9bb484c218b50d238fafcb592
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7979-7986 (2022)
Purpose: The purpose of this study was to investigate the prognostic differences between patients with small-cell lung cancer (SCLC) with different chemosensitivity to first-line chemotherapy who developed brain metastasis (BM) as the first site of p
Externí odkaz:
https://doaj.org/article/a7613bc85fad45deb7727c620efc2380
Autor:
Chunliu Meng, Fang Wang, Jia Tian, Jia Wei, Xue Li, Kai Ren, Liming Xu, Lujun Zhao, Ping Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background and PurposeOn the basis of the promising clinical study results, thoracic radiotherapy (TRT)1 has become an integral part of treatment of synchronous oligometastatic non–small cell lung cancer (SOM-NSCLC). However, some of them experienc
Externí odkaz:
https://doaj.org/article/376477738b1a4e9db32a3586d93911bf
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivesThis retrospective study investigated prognostic factors in advanced lung adenocarcinoma (LUAD) with one to five bone-only metastasis (BOM) and developed a nomogram model to estimate patient survival.MethodsWe investigated patients with adv
Externí odkaz:
https://doaj.org/article/d4826e1130fb47908d4a6d560b9f899c
Publikováno v:
Journal of Bone Oncology, Vol 31, Iss , Pp 100394- (2021)
Objectives: This retrospective study investigated prognostic factors in advanced non-small cell lung cancer (NSCLC) with bone-only metastasis, and developed a graded prognostic assessment (GPA) model to estimate patient survival. Methods: The primary
Externí odkaz:
https://doaj.org/article/52e0841588554f32987e21cd88f2170f
Purpose: To investigate the prognostic differences between small-cell lung cancer (SCLC) patients with different chemosensitivity to first line chemotherapy who developed brain metastasis as first site of progression. Methods: Patients with brain met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::614f67bef452b8da11c69127257e08d2
https://doi.org/10.21203/rs.3.rs-1850317/v1
https://doi.org/10.21203/rs.3.rs-1850317/v1
Autor:
Jiaqi Zhang, Chunliu Meng, Ningbo Liu, Lujun Zhao, Hao Yu, Ping Wang, Xiaoming Yin, Zhiyong Yuan, Yunchuan Sun, Jing Luo, Cai Xu
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 159
In previous studies, the estimated dose of radiation to immune cells (EDRIC) showed a correlation with overall survival (OS) of patients with locally advanced non-small cell lung cancer (LA-NSCLC) who received thoracic radiotherapy. However, several
Publikováno v:
Future oncology (London, England). 16(26)
Aim: To evaluate the prognostic role of EGFR mutations in patients with multi-site metastases from non-small-cell lung cancer (NSCLC). Patients & methods: A total of 215 advanced NSCLC patients with multi-site metastases were included. The overall su